{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:04:37Z","timestamp":1784034277109,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10096-025-05128-2","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:24:02Z","timestamp":1744367042000},"page":"1729-1734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of pre-extensively drug-resistant tuberculosis in a 4-month-old infant using a regimen of bedaquiline, delamanid, and contezolid"],"prefix":"10.1007","volume":"44","author":[{"given":"Wenrui","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"9928","key":"5128_CR1","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0140-6736(14)60195-1","volume":"383","author":"HE Jenkins","year":"2014","unstructured":"Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, P\u00e9rez-V\u00e9lez CM, Pagano M, Becerra MC, Cohen T (2014) Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 383(9928):1572\u20131579","journal-title":"Lancet"},{"issue":"5","key":"5128_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5588\/ijtld.17.0357","volume":"22","author":"HE Jenkins","year":"2018","unstructured":"Jenkins HE, Yuen CM (2018) The burden of multidrug-resistant tuberculosis in children. Int J Tuberc Lung Dis 22(5):3\u20136","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"5128_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J et al (2020) Treatment of highly Drug-Resistant pulmonary tuberculosis. N Engl J Med 382(10):893\u2013902","journal-title":"N Engl J Med"},{"issue":"9","key":"5128_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2119430","volume":"387","author":"F Conradie","year":"2022","unstructured":"Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, Samoilova A, Skornykova S, Tudor E, Variava E et al (2022) Bedaquiline-Pretomanid-Linezolid regimens for Drug-Resistant tuberculosis. N Engl J Med 387(9):810\u2013823","journal-title":"N Engl J Med"},{"key":"5128_CR5","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.2147\/IDR.S469509","volume":"17","author":"YJ Xiong","year":"2024","unstructured":"Xiong YJ, Xiao Y, Xie L, Gao L, Han Y, Huang PF, Liu S, Liang YX, Wang H (2024) Contezolid for the treatment of Drug-Resistant tuberculosis in China: A clinical case series. Infect Drug Resist 17:3491\u20133499","journal-title":"Infect Drug Resist"},{"key":"5128_CR6","doi-asserted-by":"publisher","first-page":"1265923","DOI":"10.3389\/fmed.2023.1265923","volume":"10","author":"J Wang","year":"2023","unstructured":"Wang J, Ma L (2023) Tuberculosis patients with special clinical conditions treated with contezolid: three case reports and a literature review. Front Med (Lausanne) 10:1265923","journal-title":"Front Med (Lausanne)"},{"key":"5128_CR7","doi-asserted-by":"crossref","unstructured":"Sarathy J, Blanc L, Alvarez-Cabrera N, O\u2019Brien P, Dias-Freedman I, Mina M, Zimmerman M, Kaya F, Ho Liang HP, Prideaux B et al (2019) Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations. Antimicrob Agents Chemother 63(5)","DOI":"10.1128\/AAC.02516-18"},{"issue":"8020","key":"5128_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-024-07605-8","volume":"631","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lai Y, Zhou S, Ran T, Zhang Y, Zhao Z, Feng Z, Yu L, Xu J, Shi K et al (2024) Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587. Nature 631(8020):409\u2013414","journal-title":"Nature"},{"issue":"4","key":"5128_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/jpids\/piaa139","volume":"10","author":"T Madzgharashvili","year":"2021","unstructured":"Madzgharashvili T, Salindri AD, Magee MJ, Tukvadze N, Avaliani Z, Blumberg HM, Kempker RR, Lomtadze N (2021) Treatment outcomes among pediatric patients with highly Drug-Resistant tuberculosis: the role of new and repurposed Second-Line tuberculosis drugs. J Pediatr Infect Dis Soc 10(4):457\u2013467","journal-title":"J Pediatr Infect Dis Soc"},{"key":"5128_CR10","doi-asserted-by":"publisher","first-page":"717045","DOI":"10.3389\/fmicb.2021.717045","volume":"12","author":"S Khoshnood","year":"2021","unstructured":"Khoshnood S, Taki E, Sadeghifard N, Kaviar VH, Haddadi MH, Farshadzadeh Z, Kouhsari E, Goudarzi M, Heidary M (2021) Mechanism of action, resistance, synergism, and clinical implications of Delamanid against Multidrug-Resistant Mycobacterium tuberculosis. Front Microbiol 12:717045","journal-title":"Front Microbiol"},{"issue":"1","key":"5128_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40265-014-0331-4","volume":"75","author":"HA Blair","year":"2015","unstructured":"Blair HA, Scott LJ (2015) Delamanid: a review of its use in patients with multidrug-resistant tuberculosis. Drugs 75(1):91\u2013100","journal-title":"Drugs"},{"key":"5128_CR12","doi-asserted-by":"crossref","unstructured":"Jiang G, Liu R, Xue Y, Ge Q, Nie L, Lv Z, Kong Z, Shi J, Chen H, Li H et al (2025) Contezolid harbored equivalent efficacy to linezolid in tuberculosis T reatment in a prospective and randomized early bactericidal activity Study. IDR, 18:261\u2013268","DOI":"10.2147\/IDR.S499816"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:22:51Z","timestamp":1757157771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5128"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05128-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Ethics Review Committee of the Children\u2019s Hospital of Kunming Medical University. The guardians of the infant patient were contacted, and informed consent was obtained for the publication of this case report. All methods were carried out in accordance with relevant guidelines and regulations, including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}